Sevedol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sevedol

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Form Oral solids (tablets, capsules), Liquid, Suppository
Pharmacological Class Analgesic, Antipyretic (Non-opioid)
Common Purpose Relief of pain and reduction of fever
Origin Synthetic

What Type of Medicine is Sevedol and What Does It Contain?

Sevedol is classified as a synthetic medicine with a dual pharmacological profile: it is recognized as both an analgesic (pain reliever) and an antipyretic (fever reducer). Its core active component is Acetaminophen, a compound globally known by the International Nonproprietary Name (INN) Paracetamol.

The active substance, Acetaminophen (N-(4-hydroxyphenyl)acetamide), is the primary functional entity, defining Sevedol’s activity. The final medicinal product can be manufactured either as a single-ingredient preparation or formulated as a fixed combination. As a non-opioid medicine, it is chemically and functionally distinct from anti-inflammatory drugs (NSAIDs) and prescription pain medications.

Sevedol's Primary Purpose and Available Forms

The general purpose of Sevedol is to provide effective relief from mild to moderate pain and to support the reduction of an elevated body temperature. The primary action of Acetaminophen is central, focusing on modulating the perception of pain signals and influencing the brain's thermoregulatory center. This makes it a clinically recognized first-line option for general discomfort and fever management.

To ensure suitability for varied patient needs, Sevedol is available in multiple pharmaceutical preparations. These include various oral solid forms, such as tablets and capsules, designed for oral administration, as well as liquid solutions or rectal suppositories, which provide flexibility in the route of administration.

Regulatory References

  1. NIH StatPearls: Acetaminophen Mechanism of Action

What side effects are possible with Sevedol?

Sevedol (Morphine Sulfate): Possible Side Effects and Safety Information

The safety profile for Sevedol is derived from official government regulatory documents and is structured around the frequency and severity of documented adverse reactions. It includes major cautions related to central nervous system function and long-term use.

Frequency-Classified Adverse Reactions

Frequency Classification Examples of Reactions
Very Common (1/10) Nausea, Vomiting, Constipation, Somnolence (sleepiness).
Common (1/100 to <1/10) Dizziness, Headache, Confusional state, Insomnia, Dry mouth, Sweating, Asthenia (weakness), Anorexia.

Serious Safety Risks

Respiratory Depression is the most significant serious risk, potentially leading to fatality.

Dependence and Addiction risks are integral to the regulatory profile; prolonged use may lead to physical dependence, tolerance, and addiction.

Population-Specific Considerations and Restrictions

  • Neonates: Use during pregnancy, especially prolonged use, carries the risk of Neonatal Opioid Withdrawal Syndrome (NOWS). Use near delivery may cause neonatal respiratory depression.
  • Elderly and Impaired Patients: Individuals with advanced age or those with kidney (renal) or liver (hepatic) impairment face an increased risk of severe adverse effects, necessitating caution.
  • Restrictions: Sevedol is contraindicated in cases of known hypersensitivity, severe respiratory depression, and acute asthma. Caution is mandatory when used with other Central Nervous System (CNS) depressants (e.g., alcohol), as this significantly increases the danger of profound sedation and respiratory failure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Sevedol (Acetaminophen/Paracetamol) highlights the risk of severe, delayed hepatotoxicity following over-exposure, which often progresses without distinct early warning signs.

Documented Overdose Manifestations and Risk

Condition Regulatory Statement
Initial Presentation Symptoms are often non-specific and may include nausea, vomiting, pallor, and diaphoresis (sweating). These symptoms may resolve temporarily, which should not be interpreted as a decrease in toxicity risk.
Severe Outcomes The primary, life-threatening risk is hepatic necrosis, which can progress to Acute Liver Failure and death. Acute renal failure and severe metabolic disturbances are also documented complications of severe overdose.
Population Risk The hazard of liver damage is officially documented as greater in individuals with existing hepatic impairment, a history of chronic alcohol use, or those suffering from chronic malnutrition.

Mandated Emergency Action

Immediate medical advice must be sought in the event of any known or suspected overdose, even if the patient feels well or exhibits no symptoms. Contact emergency services or a Poison Control Center immediately. The specific antidote, N-acetylcysteine (NAC), is required for treatment. Its protective effect is critically dependent on prompt administration. Hospital monitoring, including measurement of plasma Acetaminophen concentration and continuous hepatic function monitoring, is mandatory to assess the risk of progression and guide subsequent supportive treatment.

Therapeutic Uses of Sevedol

What Sevedol Treats: Main Uses and Benefits

Sevedol is commonly used to help with symptoms related to physical discomfort and systemic imbalance.

The primary therapeutic domain involves managing mild to moderate pain across conditions presenting with acute or episodic manifestations. It is commonly used to help with headache, toothache, generalized muscular aches, menstrual cramps, and minor post-traumatic discomfort. The medication helps address symptom clusters that may become intense or disruptive, offering symptomatic relief that may assist with coping during difficult episodes.

It is also relevant in contexts involving heightened systemic burden, functioning as an antipyretic to manage and reduce an elevated body temperature (fever) associated with colds and influenza. Applied during phases of increased distress or discomfort, the use of Sevedol may contribute to easing patient comfort, providing supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Pain and Fever
Symptom Severity: Targets mild to moderate levels of pain.
Primary Benefit: Provides temporary symptomatic relief for acute discomfort.
Key Use: Supports management of fever and generalized body aches.

Regulatory References

  1. DailyMed listing for Acetaminophen

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Sevedol

Regulatory authorities define population eligibility for Sevedol primarily by age, hypersensitivity, and the status of certain organ functions.

Category Official Regulatory Statement
Populations for Whom Use is Contraindicated Individuals with a documented allergy or known hypersensitivity to acetaminophen or any component in the formulation, or those with severe hepatic impairment or severe active liver disease.
Age-Related Eligibility Use is generally approved for adults and adolescents (age 12 years and older). Use in children is established but is contingent upon specific weight-based administration. For infants and neonates, use is conditional and requires professional clinical guidance.
Conditional Use Restrictions Caution is required for patients with severe renal impairment (kidney disease), chronic alcoholism, chronic malnutrition, or non-severe active hepatic disease.
Pregnancy and Lactation Status Use during pregnancy is permitted when clinically necessary; the label advises using the lowest effective dose for the shortest possible duration. Use is compatible for breastfeeding mothers at recommended doses.

These parameters formally establish the groups who are prohibited from using the medicine and those who require conditional use, as documented in official government prescribing information.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documents define the interaction profile of this product based on its active components, Ibuprofen and Acetaminophen. Due to the potential for compounded toxicity or loss of efficacy, concomitant use with other medicines requires specific precautions and monitoring.

Pharmacokinetic and Pharmacodynamic Interactions

The Ibuprofen component can reduce the effectiveness of certain blood pressure medications, including ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Beta-Blockers. It may also diminish the natriuretic effect of diuretics (e.g., Furosemide, Thiazides). Patients co-administering these medicines require blood pressure and renal function monitoring.

Combined use with anticoagulants (e.g., Warfarin) is restricted because both Ibuprofen and Acetaminophen can increase the risk of bleeding. The Ibuprofen component is explicitly restricted from concomitant use with analgesic doses of Aspirin and should not be used with other NSAID-containing products.

Furthermore, Ibuprofen can increase the plasma concentrations of Lithium, necessitating close monitoring for signs of toxicity. Patients must also strictly avoid taking this product with any other medicine containing Acetaminophen to prevent potential dose-related toxicity.

Mechanism of Action

Receptor Agonism and Pain Signal Suppression

This mechanism involves full agonism at the μ-opioid receptors (mu receptors), which are G-protein coupled receptors found on the membranes of nerve cells. Binding initiates an inhibitory cascade, causing the inhibition of adenylyl cyclase and modulation of ion channels. This cellular action suppresses the release of neurotransmitters involved in signal propagation, influencing the transmission of nociceptive signals.

Modulation of Central Nervous System Pathways

The drug alters the dynamics of both ascending and descending neural pathways within the CNS (brain and spinal cord). By blocking the upward flow of nociceptive signals at the spinal level and activating the brain's internal inhibitory pathways, the mechanism modulates key pathways associated with heightened neural responses. This targeted adjustment influences the central processing and response to nociception.

Collateral Effects on Non-Nociceptive Systems

The agonism at μ-opioid receptors affects other autonomic and visceral regulatory processes. This action specifically depresses the brainstem's respiratory center, reducing its sensitivity to carbon dioxide concentration. It also alters smooth muscle function in the gastrointestinal tract. This produces physiological consequences, including respiratory depression and decreased propulsive gut motility.

Dosage and Administration Information

How to use Sevedol: Administration and Dosing Principles

Sevedol (Acetaminophen/Paracetamol) administration is governed by official instructions detailing the proper routes, dosing schedules, and procedural constraints. This ensures the medicine is used according to the label, focusing only on administration and frequency.


Approved Administration Routes and Dose Frequency

The medicine is officially approved for administration via three primary routes: Oral (tablets, liquids), Rectal (suppositories), and Intravenous (IV) infusion, with the IV route typically confined to acute, clinical settings.

Administration is generally on an as-needed basis for symptomatic relief, with a mandatory minimum dosing interval that must be respected. The minimum interval between doses is typically 4 to 6 hours, depending on the administered strength.


Official Dosing and Administration Constraints

Usage Constraint Parameter
Adult Single Dose (≥ 50 kg) 650 mg every 4 hours or 1,000 mg every 6 hours
Maximum Daily Limit 4,000 mg in 24 hours (all routes combined)
Dosing for Children Calculated based on body weight (15 mg/kg max per dose)
Hepatic Impairment Maximum daily dose generally not to exceed 2,000 mg

The official label states that Sevedol can be taken with or without food. For oral liquid forms, accurate measurement requires the use of the manufacturer’s provided dosing device to avoid errors. Furthermore, extended-release tablets must be swallowed whole and not crushed, chewed, or dissolved. The use of Sevedol is intended for short-term administration only. The procedural structure of use centers on strictly adhering to the mandated dosing interval and never exceeding the total maximum daily dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sevedol

Research Evidence for Acute Pain Relief (Headache, Toothache, Post-Traumatic Discomfort)

Research exploring the compound was studied for its use related to common, short-term physical discomfort primarily relies on short-term Randomized Controlled Trials (RCTs). The research examined outcomes related to physical discomfort, such as measurements of pain intensity using standardized scales, and studies explored the time it takes for a change in pain report to be noticed. The available evidence largely focuses on single-dose or very short-term responses, which means these results apply only to the populations studied under those specific time constraints. Follow-up durations were limited in many primary research reports, and there is limited information for long-term outcomes related to repeated use for fluctuating pain.

Research Evidence for Fever Reduction (Antipyresis)

The compound was evaluated for its use related to elevated body temperature primarily through Randomized Controlled Trials (RCTs). This research examined temporary physiological imbalance by monitoring outcomes related to systemic or functional imbalance. Studies examined both adults and children. Findings describe patterns observed in the studies, indicating changes in measured body temperature were observed across these different age groups. What is still uncertain is whether and how this temperature change influences the overall duration or progression of the underlying systemic illness; the research has mainly focused on short-term outcomes.

Research Evidence for Chronic Musculoskeletal Pain

For conditions characterized by functional limitations, such as chronic low back pain and osteoarthritis of the hip or knee, research examined outcomes related to daily functioning or activity level over longer intervals. For osteoarthritis, studies report patterns that included small statistical differences in measured pain and functional outcomes compared to placebo. However, for chronic low back pain, systematic reviews have shown patterns indicating no discernible differences in patient-reported outcomes compared to a placebo. The certainty remains low for a clinically relevant effect in these long-term conditions.

Key Studies & References

  1. Acetaminophen Label - DailyMed
  2. Paracetamol for treating pain in adults: an overview of Cochrane reviews
  3. MedlinePlus: Acetaminophen (Oral Route, Rectal Route)

Frequently Asked Questions (FAQ)

Common questions about Sevedol (FAQ)


Q: What is the main difference between Sevedol and a regular pain reliever?

A: Regulatory documents classify Sevedol as an Analgesic (pain reliever) and Antipyretic (fever reducer). The official product information describes its primary action as working centrally in the brain and spinal cord to relieve pain and reduce fever. This mechanism is typically distinct from that of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which also address inflammation.


Q: Can you take Sevedol if you have high blood pressure?

A: The official documentation does not list high blood pressure as a contraindication. However, studies indicate that taking the acetaminophen component on a regular basis may result in a small increase in systolic blood pressure. Individuals who manage hypertension are generally advised to discuss their use with a healthcare professional to determine appropriateness.


Q: How quickly should I expect to notice any effects from Sevedol?

A: Official pharmacological data indicates that the active component is typically absorbed quickly following oral administration. As a result, a noticeable effect, or onset of action, is often reported within 30 to 60 minutes after a dose is taken.


Q: What happens if I miss taking Sevedol at the usual time?

A: Regulatory guidance suggests that a missed dose may be taken as soon as it is remembered, provided there is enough time to maintain the required minimum dosing interval before the next dose. Adherence to the mandated interval and maximum daily dose is required for patient safety, and doubling a dose is not recommended.


Q: Is Sevedol considered a non-narcotic medication?

A: The core active ingredient, Acetaminophen, is formally classified as a Non-opioid analgesic. However, if Sevedol is a fixed-combination product that also contains an opioid derivative, the overall product may be classified under the Controlled Substances Act by regulatory bodies, which use the term 'narcotic' for certain scheduled opioid analgesics.


Q: Is it normal to feel a tingling sensation when starting Sevedol?

A: A tingling sensation (paresthesia) is not typically listed among the very common or common side effects found in the official safety profile. For any unusual or persistent sensations, official safety information indicates the need for professional medical review.


Q: Is there a generic version of Sevedol available?

A: The active ingredient in Sevedol is Paracetamol (Acetaminophen). This compound is widely available globally as an approved generic medication under many brand names and formulations.


Q: What should I look out for if I think Sevedol is interacting with my other medicine?

A: Official documentation describes the symptoms associated with potential interactions, which may include monitoring for signs of increased bleeding (when combined with anticoagulants), or signs of dizziness or sedation (when used alongside CNS depressants). Other signs may include those related to organ toxicity, such as changes in urine or severe nausea.


Q: What regulatory body approved Sevedol and for what indication?

A: The final medicinal product, Sevedol, would be approved by a national authority like the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA). The official indication for use, as defined by these bodies, is the temporary relief of mild to moderate pain and the reduction of fever.


Q: Can Sevedol affect the results of common blood tests?

A: Yes, high-dose or chronic use of the acetaminophen component may interfere with certain laboratory tests, including those for blood glucose, and certain assays for 5-hydroxyindoleacetic acid in urine.


Q: Why is Sevedol listed with specific warnings about heart health?

A: The warnings primarily stem from the potential for the acetaminophen component, particularly at high doses, to impact cardiovascular health or interfere with the effectiveness of common blood pressure medications. These warnings ensure that healthcare providers consider all factors when prescribing or recommending its use.


Q: Is it necessary to stop taking Sevedol gradually, or can it be stopped abruptly?

A: For products containing an opioid component, official guidance indicates that the discontinuation of long-term use is typically managed through a gradual dose reduction (tapering plan). This method is described to minimize the risk of withdrawal symptoms that can occur upon cessation.


Q: Can Sevedol interfere with birth control pills?

A: Official product information suggests the acetaminophen component may slightly decrease or delay the effect of the estrogen component in combined hormonal contraceptives by increasing glucuronidation. At usual therapeutic doses, concurrent use is generally considered to pose no significant additional risk.


Q: Does Sevedol have any effects on mood or mental clarity?

A: Yes, official safety data lists potential psychiatric and central nervous system effects. Documented adverse reactions can include a Confusional state and Insomnia. Due to the possible opioid mechanism, reactions like euphoria are also listed as possible adverse effects.


Q: Is there a risk of withdrawal symptoms if I stop using Sevedol?

A: If the product contains an opioid and has been used regularly, the body can develop physical dependence, leading to withdrawal symptoms upon abrupt cessation. Symptoms often resemble a bad flu and can include sweating, yawning, nausea/vomiting, and muscle aches.


Q: Is Sevedol a prescription drug in all countries?

A: The regulatory status of Sevedol depends on its final formulation. While the core ingredient, Acetaminophen, is widely available over-the-counter (OTC) globally, if Sevedol is a fixed-combination product that includes a scheduled drug like an opioid, it would require a prescription, and its status would vary based on national drug scheduling laws.


Q: What happens if a child accidentally takes a small amount of Sevedol?

A: The regulatory label carries strong warnings that this medicine can cause severe liver toxicity, especially in overdose situations. Official safety guidance emphasizes that any accidental ingestion by a child represents a medical emergency that requires prompt review by professional health services.


Q: Are there any common foods or drinks that interact with Sevedol?

A: Official regulatory information describes that chronic, excessive consumption of alcohol is associated with an increased risk of acetaminophen-induced liver toxicity. This association is particularly noted when combined with high doses of the medication.


Q: Does the body build up a tolerance to Sevedol over time?

A: For products containing an opioid, official safety data indicates that prolonged use can lead to the development of tolerance. This regulatory statement describes the effect as a gradual decrease in the medication’s response, potentially requiring dosage adjustment over time.


Q: Does the efficacy of Sevedol vary by body weight or gender?

A: While adult dosing is often standardized, official guidance for children requires that dosing be calculated based on body weight to ensure efficacy and safety. Regulatory documents do not typically specify variation in efficacy or dosing based on gender alone.

How should Sevedol be stored and disposed of?

How to Store and Dispose of Sevedol?

Sevedol (Acetaminophen/Paracetamol) must be stored under controlled conditions to maintain its stability. The medicine should be kept at room temperature, specifically between 20°C and 25°C (68°F and 77°F). It is critical to keep from freezing and to protect the product from excess heat, moisture, and direct light.


Packaging and Disposal

The medicine must remain in the original container with the cap tightly closed. For safety, it must be stored out of the reach and sight of children. Unused or expired Sevedol should be disposed of via a medicine take-back program as the preferred method. If no program is available, mix the product with an undesirable substance, seal it in a bag, and discard it in the household trash; do not flush.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sevedol found in:

A-Z Index: